Literature DB >> 10753842

Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21).

M W Hess1, M G Schwendinger, E L Eskelinen, K Pfaller, M Pavelka, M P Dierich, W M Prodinger.   

Abstract

Electron microscopy was used to study the internalization and delivery of ligands for complement receptor type 2 (CR2, CD21) to endocytic compartments of B-lymphoblastoid Raji cells. Opsonized antigen was mimicked with purified C3dg conjugated to colloidal gold. C3dg-gold bound specifically to the cell surface in a time-dependent manner, and preincubation of the cells with a monoclonal antibody blocking the CR2 ligand-binding site completely inhibited any C3dg-gold binding. Notably, the binding of C3d-gold was confined to cell surface protrusions, eg, microvilli. C3dg-gold was apparently internalized through coated pits located at the bases of microvilli and could be traced to different compartments of the endocytic pathway. The morphologic characteristics and intracellular distribution of these multivesicular or multilaminar structures were compatible with those of compartments known to harbor major histocompatibility complex (MHC) class II molecules. Immunolabeling showed that the internalized C3dg-gold colocalized with MHC class II in these structures. These data provide the first ultrastructural evidence that complement-coated antigens are endocytosed by antigen-nonspecific B cells by CR2 and are delivered to the compartments in which peptide loading for antigen presentation occurs. They support the notion that CR2 may play a role in antigen presentation by B cells regardless of B-cell receptor specificity. (Blood. 2000;95:2617-2623)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753842

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  CD23+ CD21(high) CD1d(high) B cells in inflamed lymph nodes are a locally differentiated population with increased antigen capture and activation potential.

Authors:  Safiehkhatoon Moshkani; Igor I Kuzin; Funmilola Adewale; Johan Jansson; Iñaki Sanz; Edward M Schwarz; Andrea Bottaro
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

2.  Intratumoral delivery of antigen with complement C3-bound liposomes reduces tumor growth in mice.

Authors:  Alexandra Francian; Shelby Namen; Madigan Stanley; Kristine Mann; Holly Martinson; Max Kullberg
Journal:  Nanomedicine       Date:  2018-11-09       Impact factor: 5.307

3.  A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.

Authors:  Liudmila Kulik; Finnegan B Hewitt; Van C Willis; Rosa Rodriguez; Stephen Tomlinson; V Michael Holers
Journal:  Mol Immunol       Date:  2015-02       Impact factor: 4.407

4.  Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes.

Authors:  Aijun Tang; Pavla Kopeiková; Jindrich Kopeckevá
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

Review 5.  Receptors, subcellular compartments and the regulation of peripheral B cell responses: the illuminating state of anergy.

Authors:  Marcus R Clark; Azusa Tanaka; Sarah E Powers; Margaret Veselits
Journal:  Mol Immunol       Date:  2010-12-07       Impact factor: 4.407

6.  Two-step fluorescence screening of CD21-binding peptides with one-bead one-compound library and investigation of binding properties of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugates.

Authors:  Hui Ding; Wolfgang M Prodinger; Jindrich Kopecek
Journal:  Biomacromolecules       Date:  2006-11       Impact factor: 6.988

7.  Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virus.

Authors:  Zhenhua Zhang; Yongqing Li; Shufang Xu; Fuyong Chen; Li Zhang; Beiyu Jiang; Xiaoling Chen
Journal:  Virol J       Date:  2010-05-09       Impact factor: 4.099

8.  Inhibition of human natural killer cell activity by cereulide, an emetic toxin from Bacillus cereus.

Authors:  A Paananen; R Mikkola; T Sareneva; S Matikainen; M Hess; M Andersson; I Julkunen; M S Salkinoja-Salonen; T Timonen
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 9.  Allograft rejection: effect of local synthesis of complement.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

10.  Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis.

Authors:  Priyabrata Mukherjee; Resham Bhattacharya; Nancy Bone; Yean K Lee; Chitta Ranjan Patra; Shanfeng Wang; Lichun Lu; Charla Secreto; Pataki C Banerjee; Michael J Yaszemski; Neil E Kay; Debabrata Mukhopadhyay
Journal:  J Nanobiotechnology       Date:  2007-05-08       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.